Allspring Global Investments
SGMO

Allspring Global Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Allspring Global Investments’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,405
Closed -$14.6K – 2679
2023
Q3 		$14.6K Sell
24,405
-22,003
-47% -$23.6K ﹤0.01% 2567
2023
Q2 		$60.3K Buy
46,408
+34,157
+279% +$46.7K ﹤0.01% 2237
2023
Q1 		$21.6K Buy
12,251
+2,862
+30% +$8.17K ﹤0.01% 2488
2022
Q4 		$29.5K Sell
9,389
-816
-8% -$3.17K ﹤0.01% 2489
2022
Q3 		$50K Buy
10,205
+2,445
+32% +$12.6K ﹤0.01% 2357
2022
Q2 		$32K Sell
7,760
-70,945
-90% -$307K ﹤0.01% 2377
2022
Q1 		$457K Sell
78,705
-19,073
-20% -$113K ﹤0.01% 2262
2021
Q4 		$733K Buy
+97,778
New +$849K ﹤0.01% 2121

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Allspring Global Investments's SGMO Position: Q4 2023 in Review

Allspring Global Investments sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2023, closing a stake of 24,405 shares — an estimated $14.6K sold.

Allspring Global Investments first reported a position in SGMO in Q4 2021 and held it in 8 quarters. The position peaked at $733K in Q4 2021. 130 funds tracked by Wall St. Rank hold SGMO as of Q4 2023.

  • Allspring Global Investments reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 24,405 SANGAMO THERAPEUTICS INC shares in Q4 2023, an estimated $14.6K.
  • Allspring Global Investments first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's SANGAMO THERAPEUTICS INC position peaked at $733K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.